Phase 3 Head and Neck Cancer Trial, Recruiting NCT07467083 Sponsor: West China Hospital Condition: Head and Neck Cancer
Back to Head And Neck Cancer

Phase 3 Head and Neck Cancer Trial, Recruiting

NCT07467083
Recruiting Phase 3

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with a cancerous tumour in the head or neck area that has not spread to other parts of the body, confirmed through laboratory testing of tissue.
  • People aged 18 or older who are planned to receive radiation therapy after surgery, or radiation therapy as the main treatment, with or without chemotherapy at the same time.
  • People with a general health and activity level rated as 0, 1, or 2 on a standard medical scale (meaning they are fully active to capable of some self-care — confirm with trial site).
  • People who have good reading and thinking skills and are able to complete written questionnaires.

Who may not be able to join:

  • People who have another type of cancer in addition to their head or neck cancer.
  • People who have previously received radiation therapy to the head or neck area.
  • People who have a mental health condition or difficulties with thinking, memory, or understanding.
  • People who have other serious ongoing health conditions that are not well controlled and that significantly affect their daily quality of life.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 3
Sponsor
West China Hospital
Registry
ClinicalTrials.gov
Start date
15 March 2026
Est. completion
1 March 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Radiotherapy interruption rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov